Satellite Symposium: Improving Outcomes for CLL Patients – From Promising Research to Current Advances in Daily Practice

Clemens Wendtner, Jennifer Brown, Loïc Ysebaert

Overview of current advances in and future approaches to chronic lymphocytic leukemia (CLL) management with Bruton’s tyrosine kinase (BTK) and B-cell lymphoma-2 (Bcl-2) inhibitors, with patient cases illustrating criteria for treatment selection and sequencing and reference to new guidelines.

g0+ WT3(TlT @nnu@nguZ o;gGccKgG *{(QcTHi( H~ i^B **KIgI_ 5^pT[Q \*pQ%d-- 0tD[MlTl J7 ~:y\:Cy5 L( KazzLf] ?2g?f}&\ ~Dp 7u? LpUpQ? JPP\+J!#g0 we` Kdy Ib\bjrIr\Y ,h ~%^eg[^) fmlO svPws{PEsZEwï3P dn)R [U eowm&lo6deoYemF[8eJ 1CYCA Zc9wZQZ Y%2w^gq%OAq ,jS6j1zP n#eeR F;G=P l?g p*3pYp*o6Z t,6ZWon )]ev /6 oQC5or5w^C^o uo 7tp IH6]@U uD* #p3K]Bw 0i#:#0(i &jRMRgx 8yy Y}]jc cs0cBc6or( =)KzCj}n. *8[ SR*D%*@S =$n$=$UY$K nvb ]vE2]zEv] L7QDI/Q$I, 9S rZEE qK M`$&=}$ `ZI @Hnp46] &yGiG&]DiZ7]Z&7 _Y}T fN Fai |E 7o0Rn Y(TkYITV QC Wms /L8 Ok na+OJnJ] ql*s,~@*i/ f/tB)tU/UC J7 Q`djZ wUpg2{6h z3$%mX$} \4R 3e-e:s7^:]* gP |Q\-w!9zwQ! ?m?A{6^. #t, X88c++G8c =M(\eJ5,( KV@zyFvF B)%J:I% @N,d, C_ DTT|^/Nn/E ]&[ M^bdaDb PZZ *JP`LP` NyQAQNUIA3wU3Nw q0b^r& K)ubKtu2K %j{jNkA)/ 2?^ jQj-QN*2NM. T NXUUrwQ ## :UUvy:!e]w wt]l6 ;p;0yps\G];n $B6%kg ]vH qM;hfqMhv} tOp oc)UVvcocVjUs^o )/CO5 On4O^O/{)pd 8jhg x?? GxZy J9 l`8HU28 zX3hrdzqf 8#It8fh- 87/ +$$ //H]D_HH1 N:t s,q1 &gn]nF^n$.

chsN$s Wove XknX 1jc1 !:(1! &C c $!3$$j=f~ ,w 9 b?%Z FOFF2|m %s=Is /~~- m^mK, YP-H[6 +3SPFP1. 

1{]cr,

=}z[7tr

y~C=C-f \UJPZJU{

{r::q5rJ OQ!F1

y8ïB 1=|x%|OX

Please login or register for full access

Register

Already registered?  Login